Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focusing on treatments for rare diseases associated with vascular malformations, today announces that the US Food and Drug ...
who had AFib but none of the standard risk factors that would necessitate the prescription of blood thinner medication. Half of the study participants were randomly selected to receive 15 mg of ...